Market Alert: Strong Nuclear Tensions in South Asia Assessing the Fallout on Global Equity Markets
Highlights:
Outdated Policies Pose Risks
Life insurance advisers are being urged to actively review legacy insurance policies to avoid regulatory scrutiny, according to Steven Burgess, director of Compliance Refinery. Speaking at a Quotemonster roadshow in Lower Hutt, Burgess emphasized the importance of not neglecting older policies that may still be in force, even if newer, better options are available.
Regulatory Implications
Burgess warned that failing to review these policies could be interpreted by the Financial Markets Authority (FMA) as an adviser deeming the legacy product suitable for clients, potentially leading to censure. He noted that about half of the 3.3 million life insurance policies in New Zealand are legacy products, which may have unique features that are difficult to replicate in new policies.
Adviser Challenges and Best Practices
Advisers face significant challenges in dealing with legacy products, including difficulties in obtaining information from providers. Burgess advised using tools like AI for transcribing client interviews and customer relationship management (CRM) software to enhance record-keeping.
He stressed the importance of personalized advice, cautioning against the use of generic terms and templated wording. Proper documentation of both the advantages and disadvantages of replacement policies is crucial to avoid potential regulatory issues.
By taking these steps, advisers can ensure they act in their clients' best interests and stay compliant with evolving regulations.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com
Apr 24, 2025
Apr 24, 2025
Apr 23, 2025
Apr 23, 2025
Apr 22, 2025
Apr 22, 2025
Apr 17, 2025
Apr 17, 2025
Apr 16, 2025
Apr 16, 2025
The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.